While we observed relatively similar OS between patients with HER2 IHC0 and HER2-low BC, some studies have reported that patients with HER2-low tumors experience poorer OS compared to those with HER2 IHC0 tumors [19,20,21]. The gene discussed is ERBB2; the disease is breast cancer.